ROBERT KOHN: Open Payments
NPI 1003954066 · MCHENRY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,673 in 180 payments from 22 companies in 2025. Trend: 2023 $2,810 · 2024 $3,344 · 2025 $3,673
Food & beverage: $3,414Education: $260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $647 |
| Axsome Therapeutics, Inc. | 21 | $416 |
| Otsuka America Pharmaceutical, Inc. | 12 | $280 |
| Lundbeck LLC | 12 | $266 |
| PFIZER INC. | 13 | $262 |
| Neurocrine BioSciences, Inc. | 9 | $258 |
| Tris Pharma Inc | 9 | $205 |
| HARMONY BIOSCIENCES LLC | 5 | $197 |
| JAZZ PHARMACEUTICALS INC. | 4 | $175 |
| Supernus Pharmaceuticals, Inc. | 13 | $171 |
Products named: VRAYLAR, REXULTI, Auvelity, NURTEC ODT, INGREZZA, ABILIFY ASIMTUFII, XYWAV, Qelbree.
Industry payments across IL — which companies pay providers there.
